MedPath

贵州宏宇药业有限公司

Ownership
-
Established
1996-11-19
Employees
-
Market Cap
-
Website
www.holy-china.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

保妇康泡沫剂

Approval Number
国药准字Z10980092
Approval Date
Aug 1, 2024
NMPA

强力天麻杜仲胶囊

Approval Number
国药准字Z52020254
Approval Date
Aug 1, 2024
NMPA

金喉健喷雾剂

Approval Number
国药准字Z20025361
Approval Date
Aug 1, 2024
NMPA

天麻胶囊

Approval Number
国药准字Z52020415
Approval Date
Aug 1, 2024
NMPA

癃闭通胶囊

Approval Number
国药准字Z20053011
Approval Date
Dec 23, 2019
NMPA

小柴胡颗粒

Approval Number
国药准字Z52020496
Approval Date
Dec 13, 2019
NMPA

Compound Cefadroxil Capsules

Product Name
头孢氨苄甲氧苄啶胶囊
Approval Number
国药准字H52020644
Approval Date
Dec 13, 2019
NMPA

元胡止痛胶囊

Approval Number
国药准字Z52020488
Approval Date
Dec 13, 2019
NMPA

通便灵胶囊

Approval Number
国药准字Z52020255
Approval Date
Nov 14, 2019
NMPA

万金香气雾剂

Approval Number
国药准字Z20026302
Approval Date
Sep 26, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.